BioPlus Acquisition Debt
BIOSDelisted Stock | USD 10.73 0.00 0.00% |
BioPlus Acquisition Corp has over 5 Million in debt which may indicate that it relies heavily on debt financing. . BioPlus Acquisition's financial risk is the risk to BioPlus Acquisition stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
BioPlus Acquisition's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. BioPlus Acquisition's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps BioPlus Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect BioPlus Acquisition's stakeholders.
For most companies, including BioPlus Acquisition, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for BioPlus Acquisition Corp, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, BioPlus Acquisition's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that BioPlus Acquisition's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which BioPlus Acquisition is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of BioPlus Acquisition to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, BioPlus Acquisition is said to be less leveraged. If creditors hold a majority of BioPlus Acquisition's assets, the Company is said to be highly leveraged.
BioPlus |
BioPlus Acquisition Corp Debt to Cash Allocation
Many companies such as BioPlus Acquisition, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
BioPlus Acquisition Corp currently holds 5 M in liabilities with Debt to Equity (D/E) ratio of 7.23, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. BioPlus Acquisition Corp has a current ratio of 2.9, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about BioPlus Acquisition's use of debt, we should always consider it together with its cash and equity.BioPlus Acquisition Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the BioPlus Acquisition's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of BioPlus Acquisition, which in turn will lower the firm's financial flexibility.BioPlus Acquisition Corporate Bonds Issued
Understaning BioPlus Acquisition Use of Financial Leverage
BioPlus Acquisition's financial leverage ratio measures its total debt position, including all of its outstanding liabilities, and compares it to BioPlus Acquisition's current equity. If creditors own a majority of BioPlus Acquisition's assets, the company is considered highly leveraged. Understanding the composition and structure of BioPlus Acquisition's outstanding bonds gives an idea of how risky it is and if it is worth investing in.
BioPlus Acquisition Corp. does not have significant operations. The company was incorporated in 2021 and is based in New York, New York. Bioplus Acquisition operates under Shell Companies classification in the United States and is traded on NASDAQ Exchange. Please read more on our technical analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in BioPlus Stock
If you are still planning to invest in BioPlus Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioPlus Acquisition's history and understand the potential risks before investing.
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.